27 Oct 2026, 08:39 IST
Mankind Pharma Limited
HDFC Securities Limited (HSL)
The report states Mankind Pharma's revenue grew 17.3% YoY to Rs 4,338 crore, beating estimates, with net profit up 39% YoY and the stock trading at 26.5x FY29E EPS.
From HSL Prime Daily 27th Oct26, written by HDFC Securities Limited (HSL) and hosted by HDFC Sky. Orivam summarised it; the view is HDFC Securities Limited (HSL)'s, not Orivam's.
Open the original PDF on HDFC Sky →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.